论文部分内容阅读
目的观察卡前列素氨丁三醇治疗产后出血的临床价值。方法将82例产后出血孕妇按入院先后顺序分成试验组与常规组,各41例。其中试验组采用卡前列素氨丁三醇治疗,常规组采用缩宫素治疗。结果试验组产妇平均出血量少于常规组[(689.74±14.58)/(1 037.25±26.62)]m L,平均止血时间短于常规组[(49.19±10.63)/(105.32±12.51)]min,差异显著(P<0.05);试验组总有效率显著优于常规组(92.68%/78.05%),差异显著(P<0.05)。结论卡前列素氨丁三醇治疗产妇产后出血效果明显,安全性高,值得临床应用。
Objective To observe the clinical value of carboprost trometamol in the treatment of postpartum hemorrhage. Methods 82 pregnant women with postpartum hemorrhage were divided into experimental group and conventional group according to the order of hospital admission, with 41 cases in each group. The experimental group was treated with carboprost tromethamine, while the conventional group was treated with oxytocin. Results The average bleeding volume in the experimental group was less than that in the conventional group [(689.74 ± 14.58) / (1037.25 ± 26.62)] m, and the mean bleeding time was shorter than that in the conventional group [(49.19 ± 10.63) / (105.32 ± 12.51) (P <0.05). The total effective rate of the experimental group was significantly better than that of the conventional group (92.68% / 78.05%), the difference was significant (P <0.05). Conclusion Cardutilin trometamol treatment of postpartum hemorrhage obvious effect, high safety, it is worth clinical application.